{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:22:40Z","timestamp":1790292160626,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["YDZJ202601ZYTS552"],"award-info":[{"award-number":["YDZJ202601ZYTS552"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.biopha.2026.118997","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:02:33Z","timestamp":1768582953000},"page":"118997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["20(S\/R)-ginsenoside Rh1 improves type 2 diabetes via gut microbiota-modulated bile acid signaling and FXR\/TGR5-dependent GLP-1 enhancement"],"prefix":"10.1016","volume":"195","author":[{"given":"Ge","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4305-6306","authenticated-orcid":false,"given":"Shengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.118997_bib1","first-page":"2902351","article-title":"An overview of murine high fat diet as a model for type 2 diabetes mellitus","author":"Heydemann","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.biopha.2026.118997_bib2","article-title":"Trends in antidiabetic drug discovery: FDA approved drugs, new drugs in clinical trials and global sales","volume":"12","author":"Dahlen","year":"2021","journal-title":"Front Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2026.118997_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1053\/jhep.2000.7877","article-title":"Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid","volume":"31","author":"Axelson","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2026.118997_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-019-0628-3","article-title":"Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome","volume":"7","author":"Song","year":"2019","journal-title":"Microbiome"},{"key":"10.1016\/j.biopha.2026.118997_bib5","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/ncomms3384","article-title":"Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity","volume":"4","author":"Li","year":"2013","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.biopha.2026.118997_bib6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41419-020-02974-0","article-title":"The triterpenoid sapogenin (2alpha-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR\/GLP-1 axis through gut microbiota remodelling","volume":"11","author":"Xie","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2026.118997_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2337\/db16-0663","article-title":"An intestinal farnesoid X receptor-ceramide signaling axis modulates hepatic gluconeogenesis in mice","volume":"66","author":"Xie","year":"2017","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.biopha.2026.118997_bib8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.biopha.2026.118997_bib9","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.118997_bib10","doi-asserted-by":"crossref","first-page":"2356284","DOI":"10.1080\/19490976.2024.2356284","article-title":"Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis","volume":"16","author":"Pan","year":"2024","journal-title":"Gut Microbes"},{"issue":"2","key":"10.1016\/j.biopha.2026.118997_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2274124","article-title":"Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"issue":"6","key":"10.1016\/j.biopha.2026.118997_bib12","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.apsb.2021.03.038","article-title":"Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice","volume":"11","author":"Ding","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2026.118997_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107950","article-title":"The farnesoid X receptor (FXR) antagonist 7beta-isopropylchenodeoxycholic acid improves glucose metabolism in mice on a Western diet","volume":"221","author":"Stefela","year":"2025","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.118997_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jgr.2025.05.003","article-title":"In vivo metabolism, pharmacokinetics, and pharmacological activities of ginsenosides from ginseng","volume":"49","author":"Wang","year":"2025","journal-title":"J. ginseng res."},{"key":"10.1016\/j.biopha.2026.118997_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3389\/fphar.2018.00423","article-title":"Therapeutic potential of ginsenosides as an adjuvant treatment for diabetes","volume":"9","author":"Bai","year":"2018","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.biopha.2026.118997_bib16","doi-asserted-by":"crossref","first-page":"1179705","DOI":"10.3389\/fphar.2023.1179705","article-title":"Antioxidant and anti-inflammatory properties of ginsenoside Rg1 for hyperglycemia in type 2 diabetes mellitus: systematic reviews and meta-analyses of animal studies","volume":"14","author":"Xie","year":"2023","journal-title":"Front Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.biopha.2026.118997_bib17","article-title":"Ginsenoside compound K increases glucagon-like peptide-1 release and L-cell abundance in db\/db mice through TGR5\/YAP signaling","volume":"113","author":"Tian","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2026.118997_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/s-0043-124087","article-title":"Ginsenoside Rh1: a systematic review of its pharmacological properties","volume":"84","author":"Tam","year":"2018","journal-title":"Planta Med."},{"issue":"9","key":"10.1016\/j.biopha.2026.118997_bib19","first-page":"669","article-title":"20(S)-ginsenoside Rh1 alleviates T2DM induced liver injury via the Akt\/FOXO1 pathway","volume":"20","author":"Su","year":"2022","journal-title":"Chin. J. Nat. Med."},{"issue":"5","key":"10.1016\/j.biopha.2026.118997_bib20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1142\/S0192415X21500580","article-title":"Ginsenoside Rh1 improves type 2 diabetic nephropathy through AMPK\/PI3K\/Akt-mediated inflammation and apoptosis signaling pathway","volume":"49","author":"Su","year":"2021","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.biopha.2026.118997_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/molecules29010027","article-title":"Transformation of ginsenosides by Lactiplantibacillus plantarum MB11 fermentation: minor ginsenosides conversion and enhancement of anti-colorectal cancer activity","volume":"29","author":"Shen","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2026.118997_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jgr.2014.05.002","article-title":"Complete (1)H NMR and (13)C NMR spectral analysis of the pairs of 20(S) and 20(R) ginsenosides","volume":"38","author":"Yang","year":"2014","journal-title":"J. Ginseng Res."},{"issue":"5","key":"10.1016\/j.biopha.2026.118997_bib23","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1039\/C9FO00095J","article-title":"Ginsenoside Rk3 ameliorates high-fat-diet\/streptozocin induced type 2 diabetes mellitus in mice via the AMPK\/Akt signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Food Funct."},{"issue":"12","key":"10.1016\/j.biopha.2026.118997_bib24","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1007\/s00253-020-10633-9","article-title":"Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation","volume":"104","author":"Zhao","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.biopha.2026.118997_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112815","article-title":"A sensitive and efficient method for simultaneous profiling of bile acids and fatty acids by UPLC-MS\/MS","volume":"178","author":"Hu","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2026.118997_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115997","article-title":"Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles","volume":"303","author":"Zhou","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"18","key":"10.1016\/j.biopha.2026.118997_bib27","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1021\/acs.jafc.0c00605","article-title":"Hypoglycemic effect of ginsenoside Rg5 mediated partly by modulating gut microbiota dysbiosis in diabetic db\/db Mice","volume":"68","author":"Wei","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2026.118997_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.990476","article-title":"Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites","volume":"13","author":"Xie","year":"2022","journal-title":"Front Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2026.118997_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.biopha.2026.118997_bib30","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jgr.2022.03.006","article-title":"Compound K attenuates hyperglycemia by enhancing glucagon-like peptide-1 secretion through activating TGR5 via the remodeling of gut microbiota and bile acid metabolism","volume":"46","author":"Tian","year":"2022","journal-title":"J. Ginseng Res."},{"issue":"10","key":"10.1016\/j.biopha.2026.118997_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14321","article-title":"Ginsenoside Rg1 improved diabetes through regulating the intestinal microbiota in high-fat diet and streptozotocin-induced type 2 diabetes rats","volume":"46","author":"Peng","year":"2022","journal-title":"J. Food Biochem"},{"issue":"1","key":"10.1016\/j.biopha.2026.118997_bib32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/biomedicines8010008","article-title":"The gut microbiome and type 2 diabetes mellitus: discussing a complex relationship","volume":"8","author":"Sikalidis","year":"2020","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.biopha.2026.118997_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab."},{"issue":"23","key":"10.1016\/j.biopha.2026.118997_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201900608","article-title":"Capsaicin improves glucose tolerance and insulin sensitivity through modulation of the gut microbiota-bile acid-FXR axis in type 2 diabetic db\/db mice","volume":"63","author":"Hui","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"issue":"2","key":"10.1016\/j.biopha.2026.118997_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.biopha.2026.118997_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"issue":"18","key":"10.1016\/j.biopha.2026.118997_bib37","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.7150\/thno.99926","article-title":"Gut microbiota depletion and FXR inhibition exacerbates zonal hepatotoxicity of sunitinib","volume":"14","author":"Zhao","year":"2024","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.biopha.2026.118997_bib38","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1111\/bph.16320","article-title":"Ginsenosides retard atherogenesis via remodelling host-microbiome metabolic homeostasis","volume":"181","author":"Wang","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.biopha.2026.118997_bib39","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.3390\/foods12132492","article-title":"Ginsenoside Rh4 improves hepatic lipid metabolism and inflammation in a model of NAFLD by targeting the gut liver axis and modulating the FXR signaling pathway","volume":"12","author":"Yang","year":"2023","journal-title":"Foods"},{"key":"10.1016\/j.biopha.2026.118997_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154733","article-title":"Jiang-Tang-San-Huang pill alleviates type 2 diabetes mellitus through modulating the gut microbiota and bile acids metabolism","volume":"113","author":"Tawulie","year":"2023","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.biopha.2026.118997_bib41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.120.000435","article-title":"Ginsenoside Ro ameliorates high-fat diet-induced obesity and insulin resistance in mice via activation of the G protein-coupled bile acid receptor 5 pathway","volume":"377","author":"Jiang","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2026.118997_bib42","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1096\/fj.201700845R","article-title":"CREB\/CRTC2 controls GLP-1-dependent regulation of glucose homeostasis","volume":"32","author":"Lee","year":"2018","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.biopha.2026.118997_bib43","doi-asserted-by":"crossref","first-page":"12839","DOI":"10.1002\/jcp.27940","article-title":"Farnesoid X receptor interacts with cAMP response element binding protein to modulate glucagon-like peptide-1 (7-36) amide secretion by intestinal L cell","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"8","key":"10.1016\/j.biopha.2026.118997_bib44","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41401-023-01081-y","article-title":"TGR5 agonist inhibits intestinal epithelial cell apoptosis via cAMP\/PKA\/c-FLIP\/JNK signaling pathway and ameliorates dextran sulfate sodium-induced ulcerative colitis","volume":"44","author":"Yang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2026.118997_bib45","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ydbio.2010.07.026","article-title":"Mouse atonal homolog 1 directs intestinal progenitors to secretory cell rather than absorptive cell fate","volume":"346","author":"VanDussen","year":"2010","journal-title":"Dev. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2026.118997_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jphs.2020.11.005","article-title":"The ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells by regulating the RhoA\/ROCKs\/YAP signaling pathway and cytoskeleton formation","volume":"145","author":"Tian","year":"2021","journal-title":"J. Pharmacol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226000296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:05:02Z","timestamp":1773972302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226000296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":46,"alternative-id":["S0753332226000296"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.118997","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"20(S\/R)-ginsenoside Rh1 improves type 2 diabetes via gut microbiota-modulated bile acid signaling and FXR\/TGR5-dependent GLP-1 enhancement","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.118997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118997"}}